{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:30:37Z","timestamp":1777329037428,"version":"3.51.4"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2020.04917.BD"],"award-info":[{"award-number":["2020.04917.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/50006"],"award-info":[{"award-number":["UID\/50006"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Biopharmaceutical analysis is essential for ensuring the quality, safety, and efficacy of these medicines. Nonetheless, it faces significant challenges due to the complexity of these molecules and the strict regulatory standards. This work explores the strengths, limitations, opportunities, and threats in biopharmaceutical analysis, focusing on the challenges and emerging analytical technologies and their impact on biopharmaceutical development and quality control. Key challenges identified include the complexity and heterogeneity of biopharmaceuticals leading to the requirement for a broad spectrum of analytical methods, the high cost of the required analytical instrumentation, and the need for skilled professionals to implement advanced analytical techniques. Integrating artificial intelligence-driven data analysis, automation, and multi-omics approaches can significantly improve analytical precision and efficiency. However, regulatory barriers and financial constraints remain critical obstacles to widespread adoption. This work highlights the need for industry-wide collaboration to standardize methodologies and regulations, improve data integrity, and facilitate regulatory acceptance by reviewing the last 5\u00a0years of biopharmaceutical-related works. Ultimately, the continued development of biopharmaceutical analysis, driven by technological advancements and strategic investments, is crucial for biopharmaceutical development, enhancing manufacturing efficiency, and ensuring broader access to high-quality biopharmaceuticals.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s00216-025-06036-2","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T02:29:57Z","timestamp":1754965797000},"page":"373-394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Biopharmaceutical analysis \u2014 current analytical challenges, limitations, and perspectives"],"prefix":"10.1007","volume":"418","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2082-2568","authenticated-orcid":false,"given":"Diana R.","family":"Cunha","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1977-3006","authenticated-orcid":false,"given":"M. Beatriz","family":"Quinaz","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2938-0214","authenticated-orcid":false,"given":"Marcela A.","family":"Segundo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"12","key":"6036_CR1","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/s41587-022-01582-x","volume":"40","author":"G Walsh","year":"2022","unstructured":"Walsh G, Walsh E. Biopharmaceutical benchmarks 2022. Nat Biotechnol. 2022;40(12):1722\u201360. https:\/\/doi.org\/10.1038\/s41587-022-01582-x.","journal-title":"Nat Biotechnol"},{"key":"6036_CR2","doi-asserted-by":"publisher","DOI":"10.1201\/9781351013154","author":"B Behera","year":"2020","unstructured":"Behera B. Biopharmaceuticals: Challenges and opportunities, 2020. CRC Press. 2020. https:\/\/doi.org\/10.1201\/9781351013154.","journal-title":"CRC Press"},{"issue":"3","key":"6036_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/antib9030034","volume":"9","author":"D Zahavi","year":"2020","unstructured":"Zahavi D, Weiner L. Monoclonal Antibodies in Cancer Therapy. Antibodies. 2020;9(3):34. https:\/\/doi.org\/10.3390\/antib9030034.","journal-title":"Antibodies"},{"issue":"24","key":"6036_CR4","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.3390\/cells12242837","volume":"12","author":"M Delgado","year":"2023","unstructured":"Delgado M, Garcia-Sanz JA. Therapeutic Monoclonal Antibodies against Cancer: Present and Future. Cells. 2023;12(24):2837. https:\/\/doi.org\/10.3390\/cells12242837.","journal-title":"Cells"},{"issue":"4","key":"6036_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/iep.12478","volume":"104","author":"I Papaioannou","year":"2023","unstructured":"Papaioannou I, Owen JS, Y\u00e1\u00f1ez-Mu\u00f1oz RJ. Clinical applications of gene therapy for rare diseases: A review. Int J Exp Pathol. 2023;104(4):154\u201376. https:\/\/doi.org\/10.1111\/iep.12478.","journal-title":"Int J Exp Pathol"},{"key":"6036_CR6","doi-asserted-by":"publisher","unstructured":"Jefferis R. Recombinant Proteins and Monoclonal Antibodies. In: Rapp E, Reichl U (eds) Advances in Glycobiotechnology, 2021. Springer International Publishing, Cham, pp 281\u2013318. https:\/\/doi.org\/10.1007\/10_2017_32.","DOI":"10.1007\/10_2017_32"},{"key":"6036_CR7","doi-asserted-by":"publisher","first-page":"147884","DOI":"10.1016\/j.scitotenv.2021.147884","volume":"789","author":"ASB Rasmussen","year":"2021","unstructured":"Rasmussen ASB, Hammou A, Poulsen TF, Laursen MC, Hansen SF. Definition, categorization, and environmental risk assessment of biopharmaceuticals. Sci Total Environ. 2021;789:147884. https:\/\/doi.org\/10.1016\/j.scitotenv.2021.147884.","journal-title":"Sci Total Environ"},{"issue":"2","key":"6036_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.19277\/bbr.20.2.321","volume":"20","author":"KB Liew","year":"2023","unstructured":"Liew KB, Lee S-K, Ming LC, Uddin AH, Sarker ZI, Chew Y-L, Kee PE. Biopharmaceuticals: A review of their development and contribution to healthcare. Biomed Biopharm Res. 2023;20(2):118\u201342. https:\/\/doi.org\/10.19277\/bbr.20.2.321.","journal-title":"Biomed Biopharm Res"},{"key":"6036_CR9","unstructured":"Horizon GVR. Biopharmaceutical market size, share & trends analysis report by molecule (Monoclonal antibody, insulin, vaccine, hormone), by disease, by drug type, by drug development type, by formulation, by region, and segment forecasts, 2025 - 2030. GVR-4\u201368040\u2013534\u20131. 2025;225. https:\/\/www.grandviewresearch.com\/industry-analysis\/biopharmaceutical-market.\u00a0Accessed 31 Mar 2025."},{"issue":"1","key":"6036_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.56530\/lcgc.na.gi5577l2","volume":"39","author":"JR Auclair","year":"2021","unstructured":"Auclair JR, Rathore AS. The Multi-Attribute Method (MAM) for the Characterization of Biopharmaceuticals. LC GC N Am. 2021;39(1):28\u201332. https:\/\/doi.org\/10.56530\/lcgc.na.gi5577l2.","journal-title":"LC GC N Am"},{"issue":"8","key":"6036_CR11","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1021\/jasms.0c00432","volume":"32","author":"C Jakes","year":"2021","unstructured":"Jakes C, Mill\u00e1n-Mart\u00edn S, Carillo S, Scheffler K, Zaborowska I, Bones J. Tracking the Behavior of Monoclonal Antibody Product Quality Attributes Using a Multi-Attribute Method Workflow. J Am Soc Mass Spectrom. 2021;32(8):1998\u20132012. https:\/\/doi.org\/10.1021\/jasms.0c00432.","journal-title":"J Am Soc Mass Spectrom"},{"key":"6036_CR12","doi-asserted-by":"crossref","unstructured":"Mascarenhas-Melo F, Diaz M, Gon\u00e7alves MBS, Vieira P, Bell V, Viana S, Nunes S, Paiva-Santos AC, Veiga F. An overview of biosimilars\u2014development, quality, regulatory issues, and management in healthcare. Pharm. 2024; 17(2):235. https:\/\/www.mdpi.com\/1424-8247\/17\/2\/235.\u00a0Accessed 17 Mar 2025.","DOI":"10.3390\/ph17020235"},{"key":"6036_CR13","doi-asserted-by":"publisher","first-page":"106143","DOI":"10.1016\/j.microc.2021.106143","volume":"165","author":"R Ratih","year":"2021","unstructured":"Ratih R, Asmari M, Abdel-Megied AM, Elbarbry F, El Deeb S. Biosimilars: Review of regulatory, manufacturing, analytical aspects and beyond. Microchem J. 2021;165:106143. https:\/\/doi.org\/10.1016\/j.microc.2021.106143.","journal-title":"Microchem J"},{"key":"6036_CR14","unstructured":"Horizon GVR. Biosimilars market size, share & trends analysis by product (Recombinant glycosylated proteins, recombinant non-glycosylated proteins), by application (Rheumatoid arthritis, oncology), by region and segment forecasts 2023 - 2030. 978\u20131\u201368038\u2013916\u20136. 2022;70. https:\/\/www.grandviewresearch.com\/industry-analysis\/biosimilars-market.\u00a0Accessed 31 Mar 2025."},{"issue":"2","key":"6036_CR15","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.30574\/ijsra.2024.12.2.1345","volume":"12","author":"R Patel","year":"2024","unstructured":"Patel R, Patel A. Emerging analytical tools for biopharmaceuticals: A critical review of cutting-edge technologies. Int J Sci Res Arch. 2024;12(2):3017\u201332. https:\/\/doi.org\/10.30574\/ijsra.2024.12.2.1345.","journal-title":"Int J Sci Res Arch"},{"key":"6036_CR16","doi-asserted-by":"publisher","unstructured":"Ghizzani V, Ascione A, Gonnella F, Massolini G, Luciani F. Exploring imaged capillary isoelectric focusing parameters for enhanced charge variants quality control. Front Chem. 2025;13. https:\/\/doi.org\/10.3389\/fchem.2025.1536222.","DOI":"10.3389\/fchem.2025.1536222"},{"issue":"1","key":"6036_CR17","doi-asserted-by":"publisher","first-page":"e70013","DOI":"10.1002\/ansa.70013","volume":"6","author":"P Sathiyapriyan","year":"2025","unstructured":"Sathiyapriyan P, Mukherjee S, Vogel T, Essen L-O, Boerema D, Vey M, Kalina U. Current PAT Landscape in the Downstream Processing of Biopharmaceuticals. Anal Sci Adv. 2025;6(1):e70013. https:\/\/doi.org\/10.1002\/ansa.70013.","journal-title":"Anal Sci Adv"},{"issue":"2","key":"6036_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5639\/gabij.2020.0902.010","volume":"9","author":"SC Hock","year":"2020","unstructured":"Hock SC, Kian SM, Wah CL. Global challenges in the manufacture, regulation and international harmonization of GMP and quality standards for biopharmaceuticals. GaBI J. 2020;9(2):52\u201363. https:\/\/doi.org\/10.5639\/gabij.2020.0902.010.","journal-title":"GaBI J"},{"key":"6036_CR19","doi-asserted-by":"publisher","unstructured":"Puranik A, Dandekar P, Jain R. Exploring the potential of machine learning for more efficient development and production of biopharmaceuticals. Biotechnol Prog. 2022;38 (6). https:\/\/doi.org\/10.1002\/btpr.3291.","DOI":"10.1002\/btpr.3291"},{"issue":"4","key":"6036_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4155\/bio-2020-0006","volume":"12","author":"S K Shukla","year":"2020","unstructured":"K Shukla S, Gupta V. Analytical Challenges and Advancements in Bioanalysis of Therapeutic Proteins. Bioanal. 2020;12(4):207\u20139. https:\/\/doi.org\/10.4155\/bio-2020-0006.","journal-title":"Bioanal"},{"issue":"1","key":"6036_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.biotechadv.2011.05.006","volume":"30","author":"IA Kaltashov","year":"2012","unstructured":"Kaltashov IA, Bobst CE, Abzalimov RR, Wang G, Baykal B, Wang S. Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol Adv. 2012;30(1):210\u201322. https:\/\/doi.org\/10.1016\/j.biotechadv.2011.05.006.","journal-title":"Biotechnol Adv"},{"issue":"2","key":"6036_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/ph16020291","volume":"16","author":"HA Alhazmi","year":"2023","unstructured":"Alhazmi HA, Albratty M. Analytical Techniques for the Characterization and Quantification of Monoclonal Antibodies. Pharmaceuticals. 2023;16(2):291. https:\/\/doi.org\/10.3390\/ph16020291.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"6036_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jssc.202000765","volume":"44","author":"BL Duivelshof","year":"2021","unstructured":"Duivelshof BL, Murisier A, Camperi J, Fekete S, Beck A, Guillarme D, D\u2019Atri V. Therapeutic Fc-fusion proteins: Current analytical strategies. J Sep Sci. 2021;44(1):35\u201362. https:\/\/doi.org\/10.1002\/jssc.202000765.","journal-title":"J Sep Sci"},{"issue":"12","key":"6036_CR24","doi-asserted-by":"publisher","first-page":"886","DOI":"10.4049\/immunohorizons.2300102","volume":"7","author":"R Singh","year":"2023","unstructured":"Singh R, Chandley P, Rohatgi S. Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies. Immunohorizons. 2023;7(12):886\u201397. https:\/\/doi.org\/10.4049\/immunohorizons.2300102.","journal-title":"Immunohorizons"},{"issue":"1","key":"6036_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ijpharm.2015.08.041","volume":"494","author":"C Bazin","year":"2015","unstructured":"Bazin C, Cassard B, Caudron E, Prognon P, Havard L. Comparative analysis of methods for real-time analytical control of chemotherapies preparations. Int J Pharm. 2015;494(1):329\u201336. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.08.041.","journal-title":"Int J Pharm"},{"issue":"6","key":"6036_CR26","doi-asserted-by":"publisher","first-page":"e202400022","DOI":"10.1002\/cben.202400022","volume":"11","author":"R Pashang","year":"2024","unstructured":"Pashang R, Gilbride KA, Wenk J. Microbial Dynamics and Quality Monitoring in Biopharmaceutical Production. ChemBioEng Reviews. 2024;11(6):e202400022. https:\/\/doi.org\/10.1002\/cben.202400022.","journal-title":"ChemBioEng Reviews"},{"issue":"12","key":"6036_CR27","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.tibtech.2017.08.010","volume":"35","author":"YB Yu","year":"2017","unstructured":"Yu YB, Taraban MB, Wang W, Briggs KT. Improving Biopharmaceutical Safety through Verification-Based Quality Control. Trends Biotechnol. 2017;35(12):1140\u201355. https:\/\/doi.org\/10.1016\/j.tibtech.2017.08.010.","journal-title":"Trends Biotechnol"},{"key":"6036_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.talanta.2018.05.042","volume":"187","author":"E Jaccoulet","year":"2018","unstructured":"Jaccoulet E, Schweitzer-Chaput A, Toussaint B, Prognon P, Caudron E. Simple and ultra-fast recognition and quantitation of compounded monoclonal antibodies: Application to flow injection analysis combined to UV spectroscopy and matching method. Talanta. 2018;187:279\u201386. https:\/\/doi.org\/10.1016\/j.talanta.2018.05.042.","journal-title":"Talanta"},{"issue":"3","key":"6036_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pharma.2010.03.008","volume":"68","author":"C Bazin","year":"2010","unstructured":"Bazin C, Vieillard V, Astier A, Paul M. Contr\u00f4le rapide et fiable des pr\u00e9parations de chimioth\u00e9rapies \u00e0 base d\u2019anticorps monoclonaux \u00e0 l\u2019aide de l\u2019automate Multispec\u00ae. Ann Pharm Fr. 2010;68(3):163\u201377. https:\/\/doi.org\/10.1016\/j.pharma.2010.03.008.","journal-title":"Ann Pharm Fr"},{"issue":"1","key":"6036_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijpharm.2016.01.002","volume":"499","author":"F Nardella","year":"2016","unstructured":"Nardella F, Beck M, Collart-Dutilleul P, Becker G, Boulanger C, Perello L, Gairard-Dory A, Gourieux B, Ubeaud-S\u00e9quier G. A UV-Raman spectrometry method for quality control of anticancer preparations: Results after 18 months of implementation in hospital pharmacy. Int J Pharm. 2016;499(1):343\u201350. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.01.002.","journal-title":"Int J Pharm"},{"issue":"2","key":"6036_CR31","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00216-021-03727-4","volume":"414","author":"KA Esmonde-White","year":"2022","unstructured":"Esmonde-White KA, Cuellar M, Lewis IR. The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing. Anal Bioanal Chem. 2022;414(2):969\u201391. https:\/\/doi.org\/10.1007\/s00216-021-03727-4.","journal-title":"Anal Bioanal Chem"},{"issue":"2","key":"6036_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40259-022-00518-w","volume":"36","author":"R Mu","year":"2022","unstructured":"Mu R, Yuan J, Huang Y, Meissen JK, Mou S, Liang M, Rosenbaum AI. Bioanalytical Methods and Strategic Perspectives Addressing the Rising Complexity of Novel Bioconjugates and Delivery Routes for Biotherapeutics. BioDrugs. 2022;36(2):181\u201396. https:\/\/doi.org\/10.1007\/s40259-022-00518-w.","journal-title":"BioDrugs"},{"issue":"3","key":"6036_CR33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1039\/D0AN01963A","volume":"146","author":"J Camperi","year":"2021","unstructured":"Camperi J, Goyon A, Guillarme D, Zhang K, Stella C. Multi-dimensional LC-MS: the next generation characterization of antibody-based therapeutics by unified online bottom-up, middle-up and intact approaches. Analyst. 2021;146(3):747\u201369. https:\/\/doi.org\/10.1039\/D0AN01963A.","journal-title":"Analyst"},{"key":"6036_CR34","doi-asserted-by":"publisher","first-page":"121895","DOI":"10.1016\/j.jchromb.2019.121895","volume":"1137","author":"P Jiang","year":"2020","unstructured":"Jiang P, Li F, Ding J. Development of an efficient LC-MS peptide mapping method using accelerated sample preparation for monoclonal antibodies. J Chromatogr B. 2020;1137:121895. https:\/\/doi.org\/10.1016\/j.jchromb.2019.121895.","journal-title":"J Chromatogr B"},{"key":"6036_CR35","doi-asserted-by":"publisher","first-page":"115581","DOI":"10.1016\/j.jpba.2023.115581","volume":"234","author":"X Li","year":"2023","unstructured":"Li X. Recent applications of quantitative mass spectrometry in biopharmaceutical process development and manufacturing. J Pharm Biomed Anal. 2023;234:115581. https:\/\/doi.org\/10.1016\/j.jpba.2023.115581.","journal-title":"J Pharm Biomed Anal"},{"key":"6036_CR36","doi-asserted-by":"publisher","first-page":"115110","DOI":"10.1016\/j.jpba.2022.115110","volume":"223","author":"J Ma","year":"2023","unstructured":"Ma J, Pathirana C, Liu DQ, Miller SA. NMR spectroscopy as a characterization tool enabling biologics formulation development. J Pharm Biomed Anal. 2023;223:115110. https:\/\/doi.org\/10.1016\/j.jpba.2022.115110.","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"6036_CR37","doi-asserted-by":"publisher","first-page":"2200115","DOI":"10.1002\/biot.202200115","volume":"18","author":"A Tuameh","year":"2023","unstructured":"Tuameh A, Harding SE, Darton NJ. Methods for addressing host cell protein impurities in biopharmaceutical product development. Biotechnol J. 2023;18(3):2200115. https:\/\/doi.org\/10.1002\/biot.202200115.","journal-title":"Biotechnol J"},{"key":"6036_CR38","doi-asserted-by":"publisher","first-page":"464862","DOI":"10.1016\/j.chroma.2024.464862","volume":"1722","author":"V D\u2019Atri","year":"2024","unstructured":"D\u2019Atri V, Imio\u0142ek M, Quinn C, Finny A, Lauber M, Fekete S, Guillarme D. Size exclusion chromatography of biopharmaceutical products: From current practices for proteins to emerging trends for viral vectors, nucleic acids and lipid nanoparticles. J Chromatogr A. 2024;1722:464862. https:\/\/doi.org\/10.1016\/j.chroma.2024.464862.","journal-title":"J Chromatogr A"},{"key":"6036_CR39","doi-asserted-by":"publisher","first-page":"124037","DOI":"10.1016\/j.jchromb.2024.124037","volume":"1235","author":"T Cernosek","year":"2024","unstructured":"Cernosek T, Jain N, Dalphin M, Behrens S, Wunderli P. Accelerated development of a SEC-HPLC procedure for purity analysis of monoclonal antibodies using design of experiments. J Chromatogr B. 2024;1235:124037. https:\/\/doi.org\/10.1016\/j.jchromb.2024.124037.","journal-title":"J Chromatogr B"},{"issue":"12","key":"6036_CR40","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1007\/s00216-022-03982-z","volume":"414","author":"GL Losacco","year":"2022","unstructured":"Losacco GL, Hicks MB, DaSilva JO, Wang H, Potapenko M, Tsay F-R, Ahmad IAH, Mangion I, Guillarme D, Regalado EL. Automated ion exchange chromatography screening combined with in silico multifactorial simulation for efficient method development and purification of biopharmaceutical targets. Anal Bioanal Chem. 2022;414(12):3581\u201391. https:\/\/doi.org\/10.1007\/s00216-022-03982-z.","journal-title":"Anal Bioanal Chem"},{"key":"6036_CR41","doi-asserted-by":"publisher","first-page":"463873","DOI":"10.1016\/j.chroma.2023.463873","volume":"1693","author":"DR Stoll","year":"2023","unstructured":"Stoll DR, Sylvester M, Euerby MR, Buckenmaier SMC, Petersson P. A Strategy for assessing peak purity of pharmaceutical peptides in reversed-phase chromatography methods using two-dimensional liquid chromatography coupled to mass spectrometry. Part II: Development of second-dimension gradient conditions. J Chromatogr A. 2023;1693:463873. https:\/\/doi.org\/10.1016\/j.chroma.2023.463873.","journal-title":"J Chromatogr A"},{"key":"6036_CR42","doi-asserted-by":"publisher","first-page":"463874","DOI":"10.1016\/j.chroma.2023.463874","volume":"1693","author":"P Petersson","year":"2023","unstructured":"Petersson P, Buckenmaier S, Euerby MR, Stoll DR. A strategy for assessing peak purity of pharmaceutical peptides in reversed-phase chromatography methods using two-dimensional liquid chromatography coupled to mass spectrometry. Part I: Selection of columns and mobile phases. J Chromatogr A. 2023;1693:463874. https:\/\/doi.org\/10.1016\/j.chroma.2023.463874.","journal-title":"J Chromatogr A"},{"issue":"1","key":"6036_CR43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1573411015666181205114810","volume":"16","author":"A Tartaglia","year":"2020","unstructured":"Tartaglia A, Locatelli M, Samanidou V. Trends in the Analysis of Biopharmaceuticals by HPLC. Curr Anal Chem. 2020;16(1):52\u20138. https:\/\/doi.org\/10.2174\/1573411015666181205114810.","journal-title":"Curr Anal Chem"},{"issue":"1\u20132","key":"6036_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/elps.202300141","volume":"45","author":"O Stefanik","year":"2024","unstructured":"Stefanik O, Majerova P, Kovac A, Mikus P, Piestansky J. Capillary electrophoresis in the analysis of therapeutic peptides\u2014A review. Electrophoresis. 2024;45(1\u20132):120\u201364. https:\/\/doi.org\/10.1002\/elps.202300141.","journal-title":"Electrophoresis"},{"key":"6036_CR45","doi-asserted-by":"publisher","first-page":"116407","DOI":"10.1016\/j.trac.2021.116407","volume":"144","author":"H Kaur","year":"2021","unstructured":"Kaur H, Beckman J, Zhang Y, Li ZJ, Szigeti M, Guttman A. Capillary electrophoresis and the biopharmaceutical industry: Therapeutic protein analysis and characterization. TrAC, Trends Anal Chem. 2021;144:116407. https:\/\/doi.org\/10.1016\/j.trac.2021.116407.","journal-title":"TrAC, Trends Anal Chem"},{"key":"6036_CR46","doi-asserted-by":"publisher","first-page":"116975","DOI":"10.1016\/j.trac.2023.116975","volume":"160","author":"D van der Burg","year":"2023","unstructured":"van der Burg D, Josefsson L, Emmer \u00c5, S\u00e4nger \u2013 van de Griend CE. Recent capillary electrophoresis applications for upstream and downstream biopharmaceutical process monitoring. TrAC, Trends Anal Chem. 2023;160:116975. https:\/\/doi.org\/10.1016\/j.trac.2023.116975.","journal-title":"TrAC, Trends Anal Chem"},{"issue":"1\u20132","key":"6036_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/elps.202100182","volume":"43","author":"R Kumar","year":"2022","unstructured":"Kumar R, Guttman A, Rathore AS. Applications of capillary electrophoresis for biopharmaceutical product characterization. Electrophoresis. 2022;43(1\u20132):143\u201366. https:\/\/doi.org\/10.1002\/elps.202100182.","journal-title":"Electrophoresis"},{"issue":"1\u20135","key":"6036_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/10826076.2023.2284717","volume":"47","author":"X Song","year":"2024","unstructured":"Song X, Tian H, Zhang G. Application of capillary electrophoresis-sodium dodecyl sulfate in assessing the purity of monoclonal antibody biopharmaceuticals. J Liq Chromatogr Relat Technol. 2024;47(1\u20135):44\u201354. https:\/\/doi.org\/10.1080\/10826076.2023.2284717.","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"6036_CR49","doi-asserted-by":"publisher","first-page":"100512","DOI":"10.1016\/j.cobme.2023.100512","volume":"28","author":"Z Hetzler","year":"2023","unstructured":"Hetzler Z, Lott N, Dey Poonam A, Dalgan S, Wei Q. Single-use biosensors for biomanufacturing: Perspective on the state-of-the-art. Curr Opin Biomed Eng. 2023;28:100512. https:\/\/doi.org\/10.1016\/j.cobme.2023.100512.","journal-title":"Curr Opin Biomed Eng"},{"issue":"12","key":"6036_CR50","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/jssc.202200112","volume":"45","author":"K Suh","year":"2022","unstructured":"Suh K, Kyei I, Hage DS. Approaches for the detection and analysis of antidrug antibodies to biopharmaceuticals: A review. J Sep Sci. 2022;45(12):2077\u201392. https:\/\/doi.org\/10.1002\/jssc.202200112.","journal-title":"J Sep Sci"},{"issue":"1","key":"6036_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1208\/s12248-021-00671-0","volume":"24","author":"R Dash","year":"2021","unstructured":"Dash R, Singh SK, Chirmule N, Rathore AS. Assessment of Functional Characterization and Comparability of Biotherapeutics: a Review. AAPS J. 2021;24(1):15. https:\/\/doi.org\/10.1208\/s12248-021-00671-0.","journal-title":"AAPS J"},{"key":"6036_CR52","doi-asserted-by":"publisher","first-page":"116141","DOI":"10.1016\/j.jpba.2024.116141","volume":"245","author":"G Rey","year":"2024","unstructured":"Rey G, Schuetz F, Schroeder D, Kaluschke C, Wendeler MW, Hofmann I, Dumbliauskas E, Obrdlik P. Automated ELISA for potency measurements of therapeutic antibodies and antibody fragments. J Pharm Biomed Anal. 2024;245:116141. https:\/\/doi.org\/10.1016\/j.jpba.2024.116141.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"6036_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/biomedicines13010023","volume":"13","author":"P Bharali","year":"2025","unstructured":"Bharali P, Chand S, Chander H. A Cost-Effective and Robust Cell-Based Bioassay Method for Evaluating the Bioactivity of Trastuzumab-like Antibodies. Biomed. 2025;13(1):23. https:\/\/doi.org\/10.3390\/biomedicines13010023.","journal-title":"Biomed"},{"key":"6036_CR54","doi-asserted-by":"publisher","first-page":"116988","DOI":"10.1016\/j.bios.2024.116988","volume":"271","author":"DR Cunha","year":"2025","unstructured":"Cunha DR, Segundo MA, Quinaz MB. Electrochemical methods for evaluation of therapeutic monoclonal antibodies: A review. Biosens Bioelectron. 2025;271:116988. https:\/\/doi.org\/10.1016\/j.bios.2024.116988.","journal-title":"Biosens Bioelectron"},{"issue":"11","key":"6036_CR55","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3390\/pr9111996","volume":"9","author":"J Gaudreault","year":"2021","unstructured":"Gaudreault J, Forest-Nault C, De Crescenzo G, Durocher Y, Henry O. On the Use of Surface Plasmon Resonance-Based Biosensors for Advanced Bioprocess Monitoring. Processes. 2021;9(11):1996. https:\/\/doi.org\/10.3390\/pr9111996.","journal-title":"Processes"},{"issue":"2","key":"6036_CR56","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11468-023-01803-2","volume":"18","author":"A Uniyal","year":"2023","unstructured":"Uniyal A, Srivastava G, Pal A, Taya S, Muduli A. Recent Advances in Optical Biosensors for Sensing Applications: a Review. Plasmonics. 2023;18(2):735\u201350. https:\/\/doi.org\/10.1007\/s11468-023-01803-2.","journal-title":"Plasmonics"},{"key":"6036_CR57","doi-asserted-by":"publisher","first-page":"128328","DOI":"10.1016\/j.talanta.2025.128328","volume":"295","author":"DR Cunha","year":"2025","unstructured":"Cunha DR, Marques SS, Alves P, Correia-da-Silva G, Quinaz MB, Segundo MA. Automated renewable label-free optical sensor for quantification of therapeutic monoclonal antibodies. Talanta. 2025;295:128328. https:\/\/doi.org\/10.1016\/j.talanta.2025.128328.","journal-title":"Talanta"},{"key":"6036_CR58","doi-asserted-by":"publisher","unstructured":"Cunha DR, Segundo MA, Quinaz MB. Impedimetric biosensor based on gold nanostructures and concanavalin a for glycoproteins detection. Bioelectrochemistry. 2025;109042. https:\/\/doi.org\/10.1016\/j.bioelechem.2025.109042.","DOI":"10.1016\/j.bioelechem.2025.109042"},{"issue":"6","key":"6036_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.56530\/spectroscopy.at8171q5","volume":"39","author":"J Workman Jr","year":"2024","unstructured":"Workman J Jr. A Review of the Latest Spectroscopic Research in Pharmaceutical and Biopharmaceutical Applications. Spectroscopy. 2024;39(6):25\u20139. https:\/\/doi.org\/10.56530\/spectroscopy.at8171q5.","journal-title":"Spectroscopy"},{"key":"6036_CR60","doi-asserted-by":"publisher","unstructured":"Cunha DR, Quinaz MB, Segundo MA. Advancing therapeutic monoclonal antibody analysis: a sequential injection lab-on-valve approach. J Pharm Biomed Anal 2025;117060. https:\/\/doi.org\/10.1016\/j.jpba.2025.117060.","DOI":"10.1016\/j.jpba.2025.117060"},{"issue":"11","key":"6036_CR61","doi-asserted-by":"publisher","first-page":"e202300408","DOI":"10.1002\/slct.202300408","volume":"8","author":"T Misawa","year":"2023","unstructured":"Misawa T, Demizu Y. Developmental Trends of Peptide Drugs and Their Quality Assessment using Secondary Structure Analysis. ChemistrySelect. 2023;8(11):e202300408. https:\/\/doi.org\/10.1002\/slct.202300408.","journal-title":"ChemistrySelect"},{"key":"6036_CR62","doi-asserted-by":"crossref","unstructured":"Kurpiewska K, S\u0142awek J, Klonecka A, Kozak M. The promise and challenge of high pressure macromolecular crystallography. Cryst. 2023;13(4):560. https:\/\/www.mdpi.com\/2073-4352\/13\/4\/560.\u00a0Accessed 26 May 2025.","DOI":"10.3390\/cryst13040560"},{"key":"6036_CR63","doi-asserted-by":"publisher","first-page":"114945","DOI":"10.1016\/j.jpba.2022.114945","volume":"219","author":"C Jones","year":"2022","unstructured":"Jones C. Circular dichroism of biopharmaceutical proteins in a quality-regulated environment. J Pharm Biomed Anal. 2022;219:114945. https:\/\/doi.org\/10.1016\/j.jpba.2022.114945.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"6036_CR64","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.xphs.2019.10.026","volume":"109","author":"J Wen","year":"2020","unstructured":"Wen J, Batabyal D, Knutson N, Lord H, Wikstr\u00f6m M. A Comparison Between Emerging and Current Biophysical Methods for the Assessment of Higher-Order Structure of Biopharmaceuticals. J Pharm Sci. 2020;109(1):247\u201353. https:\/\/doi.org\/10.1016\/j.xphs.2019.10.026.","journal-title":"J Pharm Sci"},{"key":"6036_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.aca.2020.03.038","volume":"1112","author":"A Derenne","year":"2020","unstructured":"Derenne A, Derfoufi K-M, Cowper B, Delporte C, Goormaghtigh E. FTIR spectroscopy as an analytical tool to compare glycosylation in therapeutic monoclonal antibodies. Anal Chim Acta. 2020;1112:62\u201371. https:\/\/doi.org\/10.1016\/j.aca.2020.03.038.","journal-title":"Anal Chim Acta"},{"key":"6036_CR66","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ejpb.2021.05.013","volume":"165","author":"ME Klijn","year":"2021","unstructured":"Klijn ME, Hubbuch J. Application of ultraviolet, visible, and infrared light imaging in protein-based biopharmaceutical formulation characterization and development studies. Eur J Pharm Biopharm. 2021;165:319\u201336. https:\/\/doi.org\/10.1016\/j.ejpb.2021.05.013.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"6036_CR67","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/pharmaceutics13020172","volume":"13","author":"K Dauer","year":"2021","unstructured":"Dauer K, Pfeiffer-Marek S, Kamm W, Wagner KG. Microwell Plate-Based Dynamic Light Scattering as a High-Throughput Characterization Tool in Biopharmaceutical Development. Pharmaceutics. 2021;13(2):172. https:\/\/doi.org\/10.3390\/pharmaceutics13020172.","journal-title":"Pharmaceutics"},{"issue":"12","key":"6036_CR68","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.1021\/acs.analchem.3c05969","volume":"96","author":"RC Barrientos","year":"2024","unstructured":"Barrientos RC, Singh AN, Ukaegbu O, Hemida M, Wang H, Haidar Ahmad I, Hu H, Dunn ZD, Appiah-Amponsah E, Regalado EL. Two-Dimensional SEC-SEC-UV-MALS-dRI Workflow for Streamlined Analysis and Characterization of Biopharmaceuticals. Anal Chem. 2024;96(12):4960\u20138. https:\/\/doi.org\/10.1021\/acs.analchem.3c05969.","journal-title":"Anal Chem"},{"issue":"7","key":"6036_CR69","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.xphs.2021.12.023","volume":"111","author":"GM Bou-Assaf","year":"2022","unstructured":"Bou-Assaf GM, Budyak IL, Brenowitz M, Day ES, Hayes D, Hill J, Majumdar R, Ringhieri P, Schuck P, Lin JC. Best Practices for Aggregate Quantitation of Antibody Therapeutics by Sedimentation Velocity Analytical Ultracentrifugation. J Pharm Sci. 2022;111(7):2121\u201333. https:\/\/doi.org\/10.1016\/j.xphs.2021.12.023.","journal-title":"J Pharm Sci"},{"issue":"2","key":"6036_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.51847\/MgvdN50FBW","volume":"15","author":"A Pakalapati","year":"2024","unstructured":"Pakalapati A, Ranganadhareddy A, Kumar NNP. From Formation to Detection: Understanding Monoclonal Antibody Aggregation through Analytical Lenses. J Biochem Technol. 2024;15(2):27\u201332. https:\/\/doi.org\/10.51847\/MgvdN50FBW.","journal-title":"J Biochem Technol"},{"key":"6036_CR71","doi-asserted-by":"publisher","unstructured":"Sooram B, Gupta N, Chethireddy VR, Tripathi T, Saudagar P. Applications of Differential Scanning Calorimetry in Studying Folding and Stability of Proteins. In: Saudagar P, Tripathi T (eds) Protein Folding Dynamics and Stability: Experimental and Computational Methods, 2023. Springer Nature Singapore, Singapore, pp 37\u201360. https:\/\/doi.org\/10.1007\/978-981-99-2079-2_3.","DOI":"10.1007\/978-981-99-2079-2_3"},{"key":"6036_CR72","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-025-05780-9","author":"RA Hogan","year":"2025","unstructured":"Hogan RA, Pepi LE, Riley NM, Chalkley RJ. Comparative analysis of glycoproteomic software using a tailored glycan database. Anal Bioanal Chem. 2025. https:\/\/doi.org\/10.1007\/s00216-025-05780-9.","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"6036_CR73","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00216-020-03089-3","volume":"413","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Raidas S, Mao Y, Li N. Glycine additive facilitates site-specific glycosylation profiling of biopharmaceuticals by ion-pairing hydrophilic interaction chromatography mass spectrometry. Anal Bioanal Chem. 2021;413(5):1267\u201377. https:\/\/doi.org\/10.1007\/s00216-020-03089-3.","journal-title":"Anal Bioanal Chem"},{"issue":"6","key":"6036_CR74","doi-asserted-by":"publisher","first-page":"101828","DOI":"10.1016\/j.biologicals.2025.101828","volume":"90","author":"A Alston","year":"2025","unstructured":"Alston A, Bova RA, Hasson B. Validation of a Next Generation Sequencing Method for adventitious agents detection in a live vaccine matrix. Biologicals. 2025;90(6):101828. https:\/\/doi.org\/10.1016\/j.biologicals.2025.101828.","journal-title":"Biologicals"},{"key":"6036_CR75","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.csbj.2025.04.006","volume":"27","author":"L Grassi","year":"2025","unstructured":"Grassi L, Harris C, Zhu J, Hatton D, Dunn S. Next-generation sequencing: A powerful multi-purpose tool in cell line development for biologics production. Comput Struct Biotechnol J. 2025;27:1511\u20137. https:\/\/doi.org\/10.1016\/j.csbj.2025.04.006.","journal-title":"Comput Struct Biotechnol J"},{"issue":"7","key":"6036_CR76","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1021\/acs.molpharmaceut.2c00092","volume":"19","author":"M Kloczewiak","year":"2022","unstructured":"Kloczewiak M, Banks JM, Jin L, Brader ML. A Biopharmaceutical Perspective on Higher-Order Structure and Thermal Stability of mRNA Vaccines. Mol Pharmaceutics. 2022;19(7):2022\u201331. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00092.","journal-title":"Mol Pharmaceutics"},{"issue":"2","key":"6036_CR77","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.xphs.2016.10.017","volume":"106","author":"ML Brader","year":"2017","unstructured":"Brader ML, Baker EN, Dunn MF, Laue TM, Carpenter JF. Using X-Ray Crystallography to Simplify and Accelerate Biologics Drug Development. J Pharm Sci. 2017;106(2):477\u201394. https:\/\/doi.org\/10.1016\/j.xphs.2016.10.017.","journal-title":"J Pharm Sci"},{"key":"6036_CR78","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jpba.2018.08.024","volume":"161","author":"V H\u00e1da","year":"2018","unstructured":"H\u00e1da V, Bagdi A, Bihari Z, Tim\u00e1ri SB, Fizil \u00c1, Sz\u00e1ntay C. Recent advancements, challenges, and practical considerations in the mass spectrometry-based analytics of protein biotherapeutics: A viewpoint from the biosimilar industry. J Pharm Biomed Anal. 2018;161:214\u201338. https:\/\/doi.org\/10.1016\/j.jpba.2018.08.024.","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"6036_CR79","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrd3746","volume":"11","author":"SA Berkowitz","year":"2012","unstructured":"Berkowitz SA, Engen JR, Mazzeo JR, Jones GB. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars. Nat Rev Drug Discov. 2012;11(7):527\u201340. https:\/\/doi.org\/10.1038\/nrd3746.","journal-title":"Nat Rev Drug Discov"},{"issue":"23","key":"6036_CR80","doi-asserted-by":"publisher","first-page":"832059","DOI":"10.3389\/fbioe.2022.832059","volume":"10","author":"N Nupur","year":"2022","unstructured":"Nupur N, Joshi S, Gulliarme D, Rathore AS. Analytical Similarity Assessment of Biosimilars: Global Regulatory Landscape, Recent Studies and Major Advancements in Orthogonal Platforms. Front Bioeng Biotechnol. 2022;10(23):832059. https:\/\/doi.org\/10.3389\/fbioe.2022.832059.","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"6036_CR81","first-page":"116","volume":"37","author":"C Tomasek","year":"2019","unstructured":"Tomasek C. Analytical Solutions for Biosimilar Characterization. Lc Gc N Am. 2019;37(2):116\u20137.","journal-title":"Lc Gc N Am"},{"issue":"5","key":"6036_CR82","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4155\/bio.13.1","volume":"5","author":"X-Y Cai","year":"2013","unstructured":"Cai X-Y, Ashleigh W, Gouty D. Analytical and Bioanalytical Assay Challenges to Support Comparability Studies for Biosimilar Drug Development. Bioanalysis. 2013;5(5):517\u201320. https:\/\/doi.org\/10.4155\/bio.13.1.","journal-title":"Bioanalysis"},{"issue":"3","key":"6036_CR83","doi-asserted-by":"publisher","first-page":"2200521","DOI":"10.1002\/jssc.202200521","volume":"46","author":"A Puranik","year":"2023","unstructured":"Puranik A, Goswami R, Sutar P, Tupe D, Rasam P, Dandekar P, Jain R. Mass spectrometry-based glycoprofiling of biopharmaceuticals by using an automated data processing tool: SimGlycan\u00ae. J Sep Sci. 2023;46(3):2200521. https:\/\/doi.org\/10.1002\/jssc.202200521.","journal-title":"J Sep Sci"},{"issue":"12","key":"6036_CR84","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1039\/D2AY01788A","volume":"15","author":"H Thakkar","year":"2023","unstructured":"Thakkar H, Eerla R, Sharma L, Shah RP. A rapid discriminative hydrogen-deuterium exchange and LC-HRMS\/MS strategy for primary and higher order structural mapping of therapeutic proteins: a case study using filgrastim. Anal Methods. 2023;15(12):1527\u201335. https:\/\/doi.org\/10.1039\/D2AY01788A.","journal-title":"Anal Methods"},{"issue":"10","key":"6036_CR85","doi-asserted-by":"publisher","first-page":"115527","DOI":"10.1016\/j.jpba.2023.115527","volume":"234","author":"S Bhattacharya","year":"2023","unstructured":"Bhattacharya S, Rathore AS. A novel filter-assisted protein precipitation (FAPP) based sample pre-treatment method for LC-MS peptide mapping for biosimilar characterization. J Pharm Biomed Anal. 2023;234(10):115527. https:\/\/doi.org\/10.1016\/j.jpba.2023.115527.","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"6036_CR86","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1021\/acsomega.3c04463","volume":"9","author":"S Ughade","year":"2024","unstructured":"Ughade S, Rana S, Nadeem M, Kumthekar R, Mahajani S, Bhambure R. Mechanistic Modeling of Size Exclusion Chromatography-Assisted In Vitro Refolding of the Recombinant Biosimilar Teriparatide (PTH-34). ACS Omega. 2024;9(3):3204\u201316. https:\/\/doi.org\/10.1021\/acsomega.3c04463.","journal-title":"ACS Omega"},{"issue":"2","key":"6036_CR87","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/biotech11020019","volume":"11","author":"M Bhatt","year":"2022","unstructured":"Bhatt M, Alok A, Kulkarni BB. Method Development and Qualification of pH-Based CEX UPLC Method for Monoclonal Antibodies. BioTech. 2022;11(2):12\u20139. https:\/\/doi.org\/10.3390\/biotech11020019.","journal-title":"BioTech"},{"issue":"1","key":"6036_CR88","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pharma.2023.09.003","volume":"82","author":"T Gupta","year":"2024","unstructured":"Gupta T, Seshadri S. Charge variants of proposed biosimilar to Omalizumab: Isolation, purification and analysis by HPLC methods. Ann Pharm Fr. 2024;82(1):64\u201371. https:\/\/doi.org\/10.1016\/j.pharma.2023.09.003.","journal-title":"Ann Pharm Fr"},{"issue":"23","key":"6036_CR89","doi-asserted-by":"publisher","first-page":"6761","DOI":"10.1007\/s00216-022-04236-8","volume":"414","author":"LMH Reinders","year":"2022","unstructured":"Reinders LMH, Klassen MD, Teutenberg T, Jaeger M, Schmidt TC. Comparison of originator and biosimilar monoclonal antibodies using HRMS, Fc affinity chromatography, and 2D-HPLC. Anal Bioanal Chem. 2022;414(23):6761\u20139. https:\/\/doi.org\/10.1007\/s00216-022-04236-8.","journal-title":"Anal Bioanal Chem"},{"issue":"12","key":"6036_CR90","doi-asserted-by":"publisher","first-page":"123896","DOI":"10.1016\/j.jchromb.2023.123896","volume":"1229","author":"S Bhattacharya","year":"2023","unstructured":"Bhattacharya S, Rathore AS. Assessment of structural and functional similarity of biosimilar products: Bevacizumab as a case study. J Chromatogr B. 2023;1229(12):123896. https:\/\/doi.org\/10.1016\/j.jchromb.2023.123896.","journal-title":"J Chromatogr B"},{"issue":"8","key":"6036_CR91","doi-asserted-by":"publisher","first-page":"123430","DOI":"10.1016\/j.jchromb.2022.123430","volume":"1209","author":"R Kamble","year":"2022","unstructured":"Kamble R, Puranik A, Narvekar A, Dandekar P, Jain R. Characterization of outcomes of amino acid modifications using a combinatorial approach to reveal physical and structural perturbations: A case study using trastuzumab biosimilar. J Chromatogr B. 2022;1209(8):123430. https:\/\/doi.org\/10.1016\/j.jchromb.2022.123430.","journal-title":"J Chromatogr B"},{"issue":"15\u201316","key":"6036_CR92","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/10826076.2022.2072329","volume":"44","author":"A Bana","year":"2021","unstructured":"Bana A, Mehta P. Similarity assessment of charge variants for bevacizumab biosimilar formulations using imaged capillary isoelectric focusing. J Liq Chromatogr Relat Technol. 2021;44(15\u201316):801\u20138. https:\/\/doi.org\/10.1080\/10826076.2022.2072329.","journal-title":"J Liq Chromatogr Relat Technol"},{"issue":"12","key":"6036_CR93","doi-asserted-by":"publisher","first-page":"782099","DOI":"10.3389\/fchem.2021.782099","volume":"9","author":"A Demelenne","year":"2021","unstructured":"Demelenne A, Ben Yahia A, Lempereur D, Crommen J, Servais AC, Fradi I, Fillet M. Comparison of Three Complementary Analytical Techniques for the Evaluation of the Biosimilar Comparability of a Monoclonal Antibody and an Fc-Fusion Protein. Front Chem. 2021;9(12):782099. https:\/\/doi.org\/10.3389\/fchem.2021.782099.","journal-title":"Front Chem"},{"issue":"5","key":"6036_CR94","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s40259-023-00607-4","volume":"37","author":"AG Mishra","year":"2023","unstructured":"Mishra AG, Deshmane RB, Thappa DK, Lona J, Ghade NS, Sonar SM, Krishnan AR. In Vitro Biological Characterization of Recombinant Insulin Aspart from Biogenomics and Originator Insulin Aspart. BioDrugs. 2023;37(5):709\u201319. https:\/\/doi.org\/10.1007\/s40259-023-00607-4.","journal-title":"BioDrugs"},{"issue":"5","key":"6036_CR95","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","volume":"22","author":"TH Baryakova","year":"2023","unstructured":"Baryakova TH, Pogostin BH, Langer R, McHugh KJ. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discov. 2023;22(5):387\u2013409. https:\/\/doi.org\/10.1038\/s41573-023-00670-0.","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"6036_CR96","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1080\/14760584.2021.1990044","volume":"20","author":"BS Alotaibi","year":"2021","unstructured":"Alotaibi BS, Buabeid M, Ibrahim NA, Kharaba ZJ, Ijaz M, Murtaza G. Recent strategies driving oral biologic administration. Expert Rev Vaccines. 2021;20(12):1587\u2013601. https:\/\/doi.org\/10.1080\/14760584.2021.1990044.","journal-title":"Expert Rev. Vaccines"},{"issue":"9","key":"6036_CR97","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrd4363","volume":"13","author":"S Mitragotri","year":"2014","unstructured":"Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov. 2014;13(9):655\u201372. https:\/\/doi.org\/10.1038\/nrd4363.","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"6036_CR98","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1080\/17425247.2023.2237408","volume":"20","author":"H Peng","year":"2023","unstructured":"Peng H, Wang J, Chen J, Peng Y, Wang X, Chen Y, Kaplan DL, Wang Q. Challenges and opportunities in delivering oral peptides and proteins. Expert Opin Drug Deliv. 2023;20(10):1349\u201369. https:\/\/doi.org\/10.1080\/17425247.2023.2237408.","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"6036_CR99","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41578-019-0156-6","volume":"5","author":"TD Brown","year":"2020","unstructured":"Brown TD, Whitehead KA, Mitragotri S. Materials for oral delivery of proteins and peptides. Nat Rev Mater. 2020;5(2):127\u201348. https:\/\/doi.org\/10.1038\/s41578-019-0156-6.","journal-title":"Nat Rev Mater"},{"issue":"13","key":"6036_CR100","doi-asserted-by":"publisher","first-page":"1901935","DOI":"10.1002\/adma.201901935","volume":"32","author":"M Dur\u00e1n-Lobato","year":"2020","unstructured":"Dur\u00e1n-Lobato M, Niu Z, Alonso MJ. Oral Delivery of Biologics for Precision Medicine. Adv Mater. 2020;32(13):1901935. https:\/\/doi.org\/10.1002\/adma.201901935.","journal-title":"Adv Mater"},{"issue":"5","key":"6036_CR101","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","volume":"20","author":"GC Terstappen","year":"2021","unstructured":"Terstappen GC, Meyer AH, Bell RD, Zhang W. Strategies for delivering therapeutics across the blood\u2013brain barrier. Nat Rev Drug Discov. 2021;20(5):362\u201383. https:\/\/doi.org\/10.1038\/s41573-021-00139-y.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"6036_CR102","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood\u2013brain barrier: Structure, regulation and drug delivery. Sig Transduct Target Ther. 2023;8(1):217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w.","journal-title":"Sig Transduct Target Ther"},{"issue":"7","key":"6036_CR103","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3390\/pharmaceutics14071476","volume":"14","author":"RJ Boado","year":"2022","unstructured":"Boado RJ. IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport. Pharmaceutics. 2022;14(7):1476. https:\/\/doi.org\/10.3390\/pharmaceutics14071476.","journal-title":"Pharmaceutics"},{"issue":"1","key":"6036_CR104","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12987-025-00659-4","volume":"22","author":"RJ Boado","year":"2025","unstructured":"Boado RJ, Bickel U, Sumbria RK. The legacy of William M. Pardridge (1947\u20132024) on the science and fields concerned with the physiology of the blood-brain barrier and the transport of drugs to the brain. Fluids Barriers CNS. 2025;22(1):46. https:\/\/doi.org\/10.1186\/s12987-025-00659-4.","journal-title":"Fluids Barriers CNS"},{"issue":"7","key":"6036_CR105","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ddr.21832","volume":"82","author":"S Verma","year":"2021","unstructured":"Verma S, Goand UK, Husain A, Katekar RA, Garg R, Gayen JR. Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability. Drug Dev Res. 2021;82(7):927\u201344. https:\/\/doi.org\/10.1002\/ddr.21832.","journal-title":"Drug Dev Res"},{"issue":"9","key":"6036_CR106","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3390\/pharmaceutics16091207","volume":"16","author":"E Basar","year":"2024","unstructured":"Basar E, Mead H, Shum B, Rauter I, Ay C, Skaletz-Rorowski A, Brockmeyer NH. Biological Barriers for Drug Delivery and Development of Innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A\/B. Pharmaceutics. 2024;16(9):1207. https:\/\/doi.org\/10.3390\/pharmaceutics16091207.","journal-title":"Pharmaceutics"},{"issue":"11","key":"6036_CR107","doi-asserted-by":"publisher","first-page":"831","DOI":"10.4155\/bio-2022-0057","volume":"14","author":"C Tron","year":"2022","unstructured":"Tron C, Lemaitre F, Bros P, Goulvestre C, Franck B, Mouton N, Bagnos S, Coriat R, Khoudour N, Lebert D, Blanchet B. Quantification of Infliximab and Adalimumab in Human Plasma by a Liquid Chromatography Tandem Mass Spectrometry Kit and Comparison with Two ELISA Methods. Bioanalysis. 2022;14(11):831\u201344. https:\/\/doi.org\/10.4155\/bio-2022-0057.","journal-title":"Bioanalysis"},{"issue":"1","key":"6036_CR108","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12987-018-0108-3","volume":"15","author":"NR Wevers","year":"2018","unstructured":"Wevers NR, Kasi DG, Gray T, Wilschut KJ, Smith B, van Vught R, Shimizu F, Sano Y, Kanda T, Marsh G, Trietsch SJ, Vulto P, Lanz HL, Obermeier B. A perfused human blood\u2013brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport. Fluids Barriers CNS. 2018;15(1):23. https:\/\/doi.org\/10.1186\/s12987-018-0108-3.","journal-title":"Fluids Barriers CNS"},{"issue":"10","key":"6036_CR109","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/biomedicines10102447","volume":"10","author":"W Ban","year":"2022","unstructured":"Ban W, You Y, Yang Z. Imaging Technologies for Cerebral Pharmacokinetic Studies: Progress and Perspectives. Biomedicines. 2022;10(10):2447. https:\/\/doi.org\/10.3390\/biomedicines10102447.","journal-title":"Biomedicines"},{"issue":"11","key":"6036_CR110","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1021\/acs.chemrestox.1c00195","volume":"34","author":"S Gong","year":"2021","unstructured":"Gong S, Zhuo Y, Chen S, Hu X, Fan X-X, Wu J-L, Li N. Quantification of Osimertinib and Metabolite-Protein Modification Reveals Its High Potency and Long Duration of Effects on Target Organs. Chem Res Toxicol. 2021;34(11):2309\u201318. https:\/\/doi.org\/10.1021\/acs.chemrestox.1c00195.","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"6036_CR111","doi-asserted-by":"publisher","first-page":"e22208","DOI":"10.1096\/fj.202101644R","volume":"36","author":"W Alata","year":"2022","unstructured":"Alata W, Yogi A, Brunette E, Delaney CE, van Faassen H, Hussack G, Iqbal U, Kemmerich K, Haqqani AS, Moreno MJ, Stanimirovic DB. Targeting insulin-like growth factor-1 receptor (IGF1R) for brain delivery of biologics. FASEB J. 2022;36(3):e22208. https:\/\/doi.org\/10.1096\/fj.202101644R.","journal-title":"FASEB J"},{"issue":"11","key":"6036_CR112","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.3390\/cells10113183","volume":"10","author":"X Chen","year":"2021","unstructured":"Chen X, Liu C, Muok L, Zeng C, Li Y. Dynamic 3D On-Chip BBB Model Design, Development, and Applications in Neurological Diseases. Cells. 2021;10(11):3183. https:\/\/doi.org\/10.3390\/cells10113183.","journal-title":"Cells"},{"issue":"7","key":"6036_CR113","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/pharmaceutics15071834","volume":"15","author":"S Cheli","year":"2023","unstructured":"Cheli S, Savino D, Penagini F, Zuccotti G, Zuin G, Clementi E, Cattaneo D. Therapeutic Drug Monitoring of Anti-TNF\u03b1 Inhibitors: A Matter of Cut-Off Ranges. Pharmaceutics. 2023;15(7):1834. https:\/\/doi.org\/10.3390\/pharmaceutics15071834.","journal-title":"Pharmaceutics"},{"issue":"2","key":"6036_CR114","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3343\/alm.2020.40.2.95","volume":"40","author":"SY Lee","year":"2020","unstructured":"Lee SY. Therapeutic Drug Monitoring of Biologic Agents in the Era of Precision Medicine. 2020;40(2):95\u20136. https:\/\/doi.org\/10.3343\/alm.2020.40.2.95.","journal-title":"Therapeutic Drug Monitoring of Biologic Agents in the Era of Precision Medicine"},{"key":"6036_CR115","first-page":"101","volume":"9","author":"E Dreesen","year":"2017","unstructured":"Dreesen E, Bossuyt P, Mulleman D, Gils A, Pascual-Salcedo D. Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases. Clin Pharmacol. 2017;9:101\u201311.","journal-title":"Clin Pharmacol"},{"issue":"16","key":"6036_CR116","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.3390\/s24165143","volume":"24","author":"M Hemdan","year":"2024","unstructured":"Hemdan M, Ali MA, Doghish AS, Mageed SSA, Elazab IM, Khalil MM, Mabrouk M, Das DB, Amin AS. Innovations in Biosensor Technologies for Healthcare Diagnostics and Therapeutic Drug Monitoring: Applications, Recent Progress, and Future Research Challenges. Sensors. 2024;24(16):5143. https:\/\/doi.org\/10.3390\/s24165143.","journal-title":"Sensors"},{"issue":"2","key":"6036_CR117","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1208\/s12248-025-01050-9","volume":"27","author":"S Shubow","year":"2025","unstructured":"Shubow S, Gunsior M, Rosenberg A, Wang Y-M, Altepeter T, Guinn D, Rajabiabhari M, Kotarek J, Mould DR, Zhou H, Cheifetz AS, Garces S, Chevalier R, Gavan S, Trusheim MR, Rispens T, Bray K, Partridge MA. Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities \u2013 a Workshop Report. AAPS J. 2025;27(2):62. https:\/\/doi.org\/10.1208\/s12248-025-01050-9.","journal-title":"AAPS J"},{"issue":"1","key":"6036_CR118","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12014-024-09464-x","volume":"21","author":"A Hentschel","year":"2024","unstructured":"Hentschel A, Piontek G, Dahlmann R, Findeisen P, Sakson R, Carbow P, Renn\u00e9 T, Reinders Y, Sickmann A. Highly sensitive therapeutic drug monitoring of infliximab in serum by targeted mass spectrometry in comparison to ELISA data. Clin proteomics. 2024;21(1):16. https:\/\/doi.org\/10.1186\/s12014-024-09464-x.","journal-title":"Clin proteomics"},{"key":"6036_CR119","unstructured":"Reinders Y, Hentschel A, Sickmann A. Mass Spectrometry in therapeutic drug monitoring. Wiley, Analytical Science. Clinical Research and Diagnostics. 2024. https:\/\/analyticalscience.wiley.com\/content\/article-do\/mass-spectrometry-therapeutic-drug-monitoring.\u00a0Accessed 27 May 2025."},{"issue":"6","key":"6036_CR120","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1039\/D3SD00131H","volume":"2","author":"EA van Aalen","year":"2023","unstructured":"van Aalen EA, de Vries IR, Hanckmann ETL, Stevens JRF, Romagnoli TR, Derijks LJJ, Broeren MAC, Merkx M. Point-of-care therapeutic drug monitoring of tumour necrosis factor-\u03b1 inhibitors using a single step immunoassay. Sens diagn. 2023;2(6):1492\u2013500. https:\/\/doi.org\/10.1039\/D3SD00131H.","journal-title":"Sens diagn"},{"issue":"1","key":"6036_CR121","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1039\/D3SD00126A","volume":"3","author":"E Campbell","year":"2024","unstructured":"Campbell E, Adamson H, Luxton T, Tiede C, W\u00e4lti C, Tomlinson DC, Jeuken LJC. Therapeutic drug monitoring of immunotherapies with novel Affimer\u2013NanoBiT sensor construct. Sens diagn. 2024;3(1):104\u201311. https:\/\/doi.org\/10.1039\/D3SD00126A.","journal-title":"Sens diagn"},{"issue":"4","key":"6036_CR122","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1208\/s12248-012-9388-8","volume":"14","author":"X Xu","year":"2012","unstructured":"Xu X, Vugmeyster Y. Challenges and Opportunities in Absorption, Distribution, Metabolism, and Excretion Studies of Therapeutic Biologics. AAPS J. 2012;14(4):781\u201391. https:\/\/doi.org\/10.1208\/s12248-012-9388-8.","journal-title":"AAPS J"},{"key":"6036_CR123","doi-asserted-by":"publisher","unstructured":"D\u00fcrauer A, Jungbauer A, Scharl T. Monitoring product quantity, purity and potency of biopharmaceuticals in real-time by predictive chemometrics and soft sensors. Authorea Preprints. 2023. https:\/\/doi.org\/10.22541\/au.167898784.45653707\/v1.","DOI":"10.22541\/au.167898784.45653707\/v1"},{"issue":"3","key":"6036_CR124","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.tibtech.2023.08.008","volume":"42","author":"AS Rathore","year":"2024","unstructured":"Rathore AS, Sarin D. What should next-generation analytical platforms for biopharmaceutical production look like? Trends Biotechnol. 2024;42(3):282\u201392. https:\/\/doi.org\/10.1016\/j.tibtech.2023.08.008.","journal-title":"Trends Biotechnol"},{"issue":"16","key":"6036_CR125","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1007\/s00216-023-04752-1","volume":"415","author":"M Lioi","year":"2023","unstructured":"Lioi M, Tengattini S, Bagatin F, Galliani S, Daly S, Massolini G, Temporini C. Development of a rapid, efficient, and reusable magnetic bead-based immunocapture system for recombinant human procollagen type II isolation from yeast fermentation broth. Anal Bioanal Chem. 2023;415(16):3155\u201366. https:\/\/doi.org\/10.1007\/s00216-023-04752-1.","journal-title":"Anal Bioanal Chem"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-025-06036-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-025-06036-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-025-06036-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T13:36:13Z","timestamp":1767879373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-025-06036-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":125,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6036"],"URL":"https:\/\/doi.org\/10.1007\/s00216-025-06036-2","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no financial or non-financial conflicts of interest for any of the co-authors. Marcela A. Segundo is editor of\n                      Analytical and Bioanalytical Chemistry\n                      but was not involved in the peer review of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}